IGC Pharma, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
IGC Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- IGC Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$2.38M, a 14.6% decline year-over-year.
- IGC Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$13.3M, a 23.2% decline year-over-year.
- IGC Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$13M, a 13% decline from 2022.
- IGC Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$11.5M, a 23.4% increase from 2021.
- IGC Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$15M, a 70.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)